|
Market Closed -
Nasdaq
21:00:00 22/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.960 USD | +3.98% |
|
+5.31% | -14.04% |
Company Valuation: Unicycive Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 132.9 | - | - |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 7.15% | - | - |
| Enterprise Value (EV) | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 132.9 | 132.9 | 132.9 |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 7.15% | 0% | 0% |
| P/E | -2.4x | -0.45x | -0.68x | -1.42x | -3.46x | -3.88x | 2.63x | 0.56x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0x | -0.1x | 0x | 0x | 0.1x | -0x | 0x |
| Capitalization / Revenue | - | 8.57x | 44.7x | - | - | 362x | 0.88x | 0.24x |
| EV / Revenue | - | 0x | 0x | - | - | 362x | 0.88x | 0.24x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.48x | 2.27x | 0.36x |
| EV / FCF | -0x | - | -0x | -0x | -0x | -4.08x | -6.42x | 0.88x |
| FCF Yield | -18.8% | - | -60.7% | -34.8% | -25.3% | -24.5% | -15.6% | 114% |
| Dividend per Share 2 | - | - | - | - | - | - | 2.08 | 5.37 |
| Rate of return | - | - | - | - | - | - | 43.6% | 113% |
| EPS 2 | -8.6 | -12 | -12.8 | -5.6 | -1.67 | -1.229 | 1.813 | 8.45 |
| Distribution rate | - | - | - | - | - | - | 115% | 63.6% |
| Net sales 1 | - | 0.951 | 0.675 | - | - | 0.3667 | 150.2 | 548.1 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -8.977 | -18.05 | -20.77 | -32.12 | -29.52 | -38.17 | 58.62 | 369.9 |
| Net income 1 | -10.02 | -18.06 | -31.41 | -37.82 | -26.56 | -34.62 | 56.21 | 349.6 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 20.600 | 5.400 | 8.677 | 7.942 | 5.770 | 4.770 | 4.770 | 4.770 |
| Nbr of stocks (in thousands) | 1,497 | 1,509 | 3,475 | 10,380 | 21,491 | 27,855 | - | - |
| Announcement Date | 31/03/22 | 31/03/23 | 28/03/24 | 31/03/25 | 30/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.88x | - | - | - | 133M | |
| 21.82x | 7.74x | 15.55x | 1.36% | 74.33B | |
| 32.35x | 9.35x | 29.12x | 0.04% | 62.26B | |
| 32.02x | 6.83x | 17.73x | -.--% | 27.72B | |
| -73.86x | 14.28x | -68.86x | -.--% | 26.42B | |
| -14.99x | 5.59x | -7.02x | -.--% | 24.62B | |
| 28.25x | 5.33x | 17.69x | -.--% | 20.72B | |
| 43.37x | 15.89x | 32.23x | 0.35% | 15.01B | |
| 17.67x | 5.26x | 12.29x | -.--% | 14.18B | |
| -14.6x | 3288.74x | -16.82x | -.--% | 13.48B | |
| Average | 6.81x | 373.22x | 3.54x | 0.19% | 27.89B | |
| Weighted average by Cap. | 12.52x | 167.26x | 8.13x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- UNCY Stock
- Valuation Unicycive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
